Rocket Doctor AI to Present at the 2025 CANTech Letter Conference in Toronto
Rocket Doctor AI (OTCQB: AIRDF), a healthcare technology company, will present at the 2025 CANTech Letter Conference in Toronto on October 9, 2025. CEO Dr. Essam Hamza and Rocket Doctor Inc. Founder Dr. William Cherniak will deliver their presentation at 2:30 PM ET in Track 1.
The presentation will showcase the company's AI-powered healthcare platform, which focuses on improving healthcare accessibility and patient outcomes through streamlined workflows and reduced administrative friction. The company's leadership will discuss their platform innovations, recent milestones, and growth strategy.
Rocket Doctor AI (OTCQB: AIRDF), un'azienda di tecnologia sanitaria, parteciperà alla 2025 CANTech Letter Conference a Toronto il 9 ottobre 2025. Il CEO, il dottor Essam Hamza, e il fondatore di Rocket Doctor Inc., il dottor William Cherniak, terranno la loro presentazione alle 2:30 PM ET nel Track 1. La presentazione metterà in evidenza la piattaforma sanitaria alimentata dall'IA dell'azienda, che punta a migliorare l'accessibilità alle cure e gli esiti per i pazienti tramite flussi di lavoro snelli e minore frizione amministrativa. La leadership dell'azienda discuterà delle innovazioni della piattaforma, dei recenti traguardi e della strategia di crescita.
Rocket Doctor AI (OTCQB: AIRDF), una empresa de tecnología sanitaria, participará en la Conference Letters 2025 de CANTech en Toronto el 9 de octubre de 2025. El CEO, el Dr. Essam Hamza, y el fundador de Rocket Doctor Inc., el Dr. William Cherniak, presentarán a las 2:30 PM ET en la Pista 1. La presentación mostrará la plataforma de salud impulsada por IA de la empresa, centrada en mejorar el acceso a la atención sanitaria y los resultados de los pacientes mediante flujos de trabajo optimizados y menor fricción administrativa. El equipo directivo discutirá las innovaciones de la plataforma, los hitos recientes y la estrategia de crecimiento.
Rocket Doctor AI (OTCQB: AIRDF)는 의료 기술 기업으로, 2025 CANTech Letter Conference를 토론토에서 2025년 10월 9일에 발표합니다. CEO Essam Hamza 박사와 Rocket Doctor Inc. 창립자 William Cherniak 박사는 ET 기준 2:30 PM에 Track 1에서 발표를 진행합니다. 발표는 회사의 AI 기반 헬스케어 플랫폼을 선보이며, 간소화된 워크플로와 행정적 마찰 감소를 통해 의료 접근성과 환자 결과를 개선하는 데 초점을 맞춥니다. 회사의 리더십은 플랫폼의 혁신, 최근 이정표 및 성장 전략에 대해 논의할 예정입니다.
Rocket Doctor AI (OTCQB : AIRDF), une entreprise de technologie de la santé, participera à la conférence 2025 CANTech Letter à Toronto le 9 octobre 2025. Le PDG, le Dr Essam Hamza, et le fondateur de Rocket Doctor Inc., le Dr William Cherniak, présenteront à 14h30 HE sur la piste 1. La présentation mettra en avant la plateforme de soins de santé alimentée par l'IA de l'entreprise, axée sur l'amélioration de l'accès aux soins et des résultats des patients grâce à des flux de travail rationalisés et à une friction administrative réduite. La direction discutera des innovations de la plateforme, des jalons récents et de la stratégie de croissance.
Rocket Doctor AI (OTCQB: AIRDF), ein Gesundheits-Technologieunternehmen, wird auf der 2025 CANTech Letter Conference in Toronto am 9. Oktober 2025 präsentieren. CEO Dr. Essam Hamza und der Gründer von Rocket Doctor Inc., Dr. William Cherniak, halten ihre Präsentation um 14:30 Uhr ET auf Track 1. Die Präsentation wird die KI-gestützte Gesundheitsplattform des Unternehmens vorstellen, die darauf abzielt, den Zugang zur Gesundheitsversorgung zu verbessern und die Ergebnisse der Patienten durch optimierte Arbeitsabläufe und reduzierten administrative Aufwand zu verbessern. Die Führung des Unternehmens wird über Plattform-Innovationen, jüngste Meilensteine und Wachstumsstrategie sprechen.
Rocket Doctor AI (OTCQB: AIRDF)، الشركة المتخصصة في تكنولوجيا الرعاية الصحية، ستقدم عرضًا في مؤتمر CANTech Letter 2025 في تورنتو يوم 9 أكتوبر 2025. سيقدم الرئيس التنفيذي الدكتور عِصام حمزة ومؤسس Rocket Doctor Inc. الدكتور ويليام تشيرنيك عرضهُما في الساعة 2:30 مساءً بتوقيت شرق الولايات المتحدة في المسار 1. سيُبرز العرض منصة الرعاية الصحية المدعومة بالذكاء الاصطناعي للشركة، التي تركّز على تحسين إمكانية الوصول إلى الرعاية الصحية ونتائج المرضى من خلال سير عمل مبسّط وتقليل العوائق الإدارية. ستناقش قيادة الشركة ابتكارات المنصة والتطورات الأخيرة واستراتيجية النمو.
Rocket Doctor AI (OTCQB: AIRDF),一家医疗科技公司,将于 2025 CANTech Letter Conference 在多伦多举行,时间为 2025年10月9日。CEO Essam Hamza 博士与 Rocket Doctor Inc. 创始人 William Cherniak 博士将于 东部时间下午2:30 在 Track 1 进行演讲。此次演讲将展示公司基于人工智能的医疗平台,专注于通过简化工作流程和减少行政摩擦来提升医疗可及性与患者结局。公司领导层将讨论平台创新、最近里程碑以及增长策略。
- None.
- None.
- Rocket Doctor AI CEO, Dr. Essam Hamza and Rocket Doctor Inc. Founder & CEO,
Dr. William Cherniak to present live at 2:30 PM ET in Track 1 on October 9, 2025. - Presentation will highlight Rocket Doctor AI's platform innovations, recent milestones, and growth strategy.
- Attendees can register and learn more at conference.cantechletter.com/
Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Rocket Doctor AI Inc. (CSE: AIDR) (OTCQB: AIRDF) (FSE: 939) ("Rocket Doctor AI") a healthcare technology company focused on delivering physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey, is pleased to announce its participation at the upcoming CANTech Letter Investment Conference on Thursday, October 9, 2025, in Toronto, Ontario. Rocket Doctor AI's CEO, Dr. Essam Hamza, and Founder & CEO of Rocket Doctor Inc., Dr. William Cherniak, will present an overview of the company's platform, solutions, recent milestones, and growth strategy.
2025 CANTech Letter Conference
Date: Thursday, October 9, 2025
Time: 2:30-3:00 PM Eastern Time in Track 1
Location: Toronto, Ontario (venue as listed by conference organizers)
Contact: Please register via the conference website
More info: https://conference.cantechletter.com/
Dr. Essam Hamza commented, "CANTech brings together Canada's most engaged technology investors and operators. Dr. Bill Cherniak and I are excited to share how Rocket Doctor AI is deploying clinician-led, pragmatic AI platforms to streamline workflows, reduce administrative friction, and ultimately improve patient access and outcomes."
Attendees of the 2025 CANTech Letter Conference can join the Rocket Doctor AI session in Track 1 at 2:30 PM ET. For event details and registration, please visit the conference website.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.
Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.
To learn more about Rocket Doctor AI Inc's products and services, contact:
www.rocketdoctor.ai or email: info@rocketdoctor.ai
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io
For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321
Cautionary Statements
This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Offering, the use of proceeds of the Offering, the filing of a Prospectus Supplement and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268365